rLCMV-Cl13/GP_F38L


EVAg

Produced by
: UNIBAS
Shipping From
: Basel - CH

Product Description

Ref-SKU:
006V-03030
Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa38 (phenylalanine to leucine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented and H-2Kb-presented GP33-41 and GP34-41 CD8+ T cell epitopes, respectively, of C57BL/6 mice.
Product Risk Group: 
Subspecies: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial containing 1 ml

In stock

480,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
BSL2
Virus host type: 
Infectivity Test: 
Plaque forming assay
Viral titer: 
8.3x10^5
Production cell line: 
Virus Cultivability: 
Passage: 
P1
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Synthetic origin
Modifications from the reference sequence(s): 
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references
Description of modification(s) made from the reference sequence(s): 
the GP carries the mutation F38L